EMMAC Life Sciences

Biotech & Life Sciences · London, United Kingdom · Founded 2018

Vertically integrated European medical cannabis and wellness products MoreLess

Curaleaf Medical is the scientific arm of Curaleaf International. Our team focuses on advancing our understanding of the potential therapeutic value of cannabis used for medicinal purposes (also known as medical marajuana) and how we can develop products that meet the needs of people all across Europe.

Valuation $100–500M

Revenue $50–100M

Headcount 100–500

Total funding $0–10M

Unlock exact values

Power Law Colt$25–100M revenue

Talent graph

EMMAC Life Sciences's talent

Book a demo to see the people

Employees mapped 181 incl. 1 AI specialist

Founders /100 quality score

Key operators 20 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on EMMAC Life Sciences's cap table

Sourced from Dealroom's funding history.

Series A 1 investor entered at this stage

Material V

Series B+ 1 investor entered at this stage

Material V

Global footprint

Where EMMAC Life Sciences has talent and traffic

Workforce by country

11 countries with
team presence

🇵🇹 Portugal32.8%

🇬🇧 United Kingdom32.1%

🇨🇦 Canada11.2%

🇪🇸 Spain10.4%

🇺🇸 United States4.5%

Top 5 of 11 shown

Market sentiment

What the market is saying about EMMAC Life Sciences

An AI-synthesized read of the highest-engagement posts about EMMAC Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See EMMAC Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles